IMFINZI-subQ
AstraZeneca
AstraZeneca
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
Zymeworks BC Inc.
7 Hills Pharma, LLC
Nammi Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Aptamer Sciences, Inc.
Hoffmann-La Roche
3D Medicines
Tel-Aviv Sourasky Medical Center
Exelixis
Mayo Clinic
Mayo Clinic
Ohio State University
ViroMissile, Inc.
Seagen Inc.
Essen Biotech
DualityBio Inc.
MacroGenics
Hefei TG ImmunoPharma Co., Ltd.
Grey Wolf Therapeutics
Jiangsu Simcere Pharmaceutical Co., Ltd.
Zhejiang University
Wondercel Biotech (ShenZhen)
Dysplasia Diagnostics Limited
Elephas
Mayo Clinic
Degron Therapeutics Co.
Mayo Clinic
GV20 Therapeutics
West China Hospital
DualityBio Inc.
Massive Bio, Inc.
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Shanghai Public Health Clinical Center
HC Biopharma Inc.
Cofactor Genomics, Inc.
Sichuan University
National University Hospital, Singapore
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
BioEclipse Therapeutics